Inserm Transfert

France

Back to Profile

1-4 of 4 for Inserm Transfert Sort by
Query
Aggregations
IP Type
        Patent 3
        Trademark 1
Jurisdiction
        United States 2
        Europe 1
        World 1
Date
2024 1
2021 1
Before 2020 2
IPC Class
A61K 31/132 - Amines, e.g. amantadine having two or more amino groups, e.g. spermidine, putrescine 2
A61K 31/16 - Amides, e.g. hydroxamic acids 2
A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide 2
A61K 31/32 - Tin compounds 2
A61K 31/546 - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine containing further heterocyclic rings, e.g. cephalothin 2
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 1
10 - Medical apparatus and instruments 1
35 - Advertising and business services 1
36 - Financial, insurance and real estate services 1
41 - Education, entertainment, sporting and cultural services 1
See more

1.

ANDZONBIO

      
Application Number 019012637
Status Registered
Filing Date 2024-04-11
Registration Date 2024-08-22
Owner
  • INSERM TRANSFERT (France)
  • AdBio Partners (France)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Pharmaceutical preparations; Diagnostic preparations and materials For medical purposes; Diagnostic reagents for medical use. Medical apparatus and instruments; Medical devices; Medical diagnostic tools and instruments. Advertising; Business management; Business administration; Office functions; Computerized file management; Entry and processing of data, namely updating, entry, collation, systematic ordering of data; Business management consultancy via computer or data transmission means; Providing advertising and business information via the Internet, via telephone networks or by means of data transmission; Processing of data, signals and information processed by computers or by telecommunications apparatus and instruments, namely updating, entry, collation, systematic ordering of data, signals and information processed by computer or by telecommunications apparatus and instruments; Collection and systematic ordering of data in a master file; Searching and retrieval of computer business information; Computer database management; Business organisation and management consultancy; Business management consultancy; Business inquiries and information; Assistance in management of business activities; Market research and business research; Business auditing; Professional business consultancy; Organization of exhibitions for commercial or advertising purposes; Book-keeping; Document reproduction; Market research; Efficiency experts; Business research; Advertising and commercial information via the Internet; Searching for information in computer files (for others); Entry and compilation of computer data; Business management consultancy; Commercial or industrial management assistance; Business appraisals; Arranging newspaper subscriptions (for others); Professional referral services in relation to the following fields: Company formation and Business management; Planning concerning business management, namely, searching for partners for amalgamations and business take-overs as well as for business establishments; Administrative services. Financial, monetary and banking services; Insurance services; Real estate affairs; Financial analysis; Organization of monetary collections; Financial evaluation [insurance, banking, real estate]; Financing and funding services; Providing financial information via a web site; Financial management; Providing financial information; Capital investment; Fund investment services; Financial analysis and research services. Training; Teaching; Entertainment services; Arranging of colloquiums, conferences and congresses; Providing online videos, not downloadable. biological, clinical, medical and pharmacological research; Computer programming in the medical field; Medical research laboratory services; Scientific research for medical purposes; Design and development of medical technology; Design and development of medical diagnostic apparatus; Design and development of computer software for use with medical technology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Surveying [engineering]; Creation, installation, management, updating, upgrading and maintenance of computer databases, software and mobile applications; Research and development of new products for others; Software study, design, development and maintainance; Computer programming; Design, maintenance and updating of websites; Design, programming and production of website search engines; Intranet and Internet portals, namely hosting of websites that facilitate access to other websites.

2.

Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria

      
Application Number 16927840
Grant Number 11820726
Status In Force
Filing Date 2020-07-13
First Publication Date 2021-01-07
Grant Date 2023-11-21
Owner
  • UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (USA)
  • INSERM TRANSFERT, S.A. (France)
Inventor
  • Phanstiel, Iv, Otto
  • Brunel, Jean-Michel

Abstract

Motuporamine agents having antimicrobial activity and uses thereof.

IPC Classes  ?

  • C07C 211/17 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing only non-condensed rings
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/132 - Amines, e.g. amantadine having two or more amino groups, e.g. spermidine, putrescine
  • A61P 31/04 - Antibacterial agents
  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
  • A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
  • A61K 31/32 - Tin compounds
  • C07D 225/02 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
  • A61K 31/546 - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine containing further heterocyclic rings, e.g. cephalothin
  • A61K 31/65 - Tetracyclines
  • A61K 31/16 - Amides, e.g. hydroxamic acids

3.

Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria

      
Application Number 15866081
Grant Number 10710957
Status In Force
Filing Date 2018-01-09
First Publication Date 2018-09-13
Grant Date 2020-07-14
Owner
  • University of Central Florida Research Foundation, Inc. (USA)
  • Inserm Transfert, S.A. (France)
Inventor
  • Phanstiel, Iv, Otto
  • Brunel, Jean-Michel

Abstract

Motuporamine agents having antimicrobial activity and uses thereof.

IPC Classes  ?

  • C07C 211/17 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing only non-condensed rings
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/132 - Amines, e.g. amantadine having two or more amino groups, e.g. spermidine, putrescine
  • A61P 31/04 - Antibacterial agents
  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
  • A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
  • A61K 31/32 - Tin compounds
  • C07D 225/02 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
  • A61K 31/546 - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine containing further heterocyclic rings, e.g. cephalothin
  • A61K 31/65 - Tetracyclines
  • A61K 31/16 - Amides, e.g. hydroxamic acids

4.

NOVEL TRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS

      
Application Number EP2009055213
Publication Number 2009/133147
Status In Force
Filing Date 2009-04-29
Publication Date 2009-11-05
Owner
  • INSERM TRANSFERT (France)
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (France)
Inventor
  • Peng, Ling
  • Rocchi, Palma
  • Iovanna, Juan
  • Xia, Yi
  • Qu, Fanqi
  • Wan, Jinqiao
  • Liu, Yan
  • Wang, Menghua

Abstract

The present invention relates to novel compounds of formula (A): in the form of a free base or of an addition salt with an acid. The invention also relates to process of preparation of compounds of formula (A), to composition comprising them and to their application in therapeutics and in particular in cancers.

IPC Classes  ?

  • C07H 19/056 - Triazole or tetrazole radicals
  • A61K 31/7056 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
  • A61P 35/00 - Antineoplastic agents